文献速递冠心病心力衰竭与心肌病

老年STEMI合并心源性休克患者的经皮冠状动脉介入治疗

Percutaneous Coronary Intervention in Older Patients With ST-Segment Elevation Myocardial Infarction and Cardiogenic Shock.
PubMed 文献 · J Am Coll Cardiol · 2019-01-01

该研究基于美国1999至2013年全国住院患者数据库,分析年龄≥75岁STEMI合并心源性休克患者接受PCI与住院死亡率的关系。结果显示PCI使用率从27%升至56%,住院死亡率从64%降至46%,倾向评分匹配后PCI与较低住院死亡率相关(OR 0.48,95%CI 0.45-0.51)。

要点

  • 年龄≥75岁STEMI合并休克患者中,PCI使用率随时间显著增加。
  • 倾向评分匹配后PCI与住院死亡率降低相关(OR 0.48,95%CI 0.45-0.51)。
  • 无绝对禁忌时不应仅因年龄排除早期血运重建。

核心结论

  • 在老年STEMI合并心源性休克患者中,PCI使用增加与住院死亡率显著下降平行。
  • 无绝对禁忌证时,不应仅基于年龄排除早期血运重建。

研究设计与样本

  • 研究使用美国Agency for Healthcare Research and Quality赞助的1999至2013年大型全支付方住院医疗数据库。
  • 共纳入317,728例STEMI合并休克住院记录,其中111,901例(35%)为年龄≥75岁成人。
  • 主要结局为住院死亡率,采用倾向评分五分位评估PCI对住院死亡率的影响。

主要发现

  • 老年患者中女性占53%,白人占83%,慢性病中位数为8种(四分位距6至10)。
  • 老年STEMI合并休克比例从1999年42%降至2013年29%。
  • 老年患者PCI使用率从1999年27%升至2013年56%(p < 0.001),住院死亡率从64%降至46%(p < 0.001)。
  • 倾向评分匹配后,PCI与较低住院死亡风险相关(Mantel-Haenszel OR 0.48,95%CI 0.45-0.51)。
  • 四个美国人口普查区域均见住院死亡风险降低(调整OR:东北0.41,95%CI 0.36-0.47;中西部0.49,95%CI 0.42-0.57;南部0.51,95%CI 0.46-0.56;西部0.46,95%CI 0.41-0.53)。

临床怎么用

  • 对年龄≥75岁STEMI合并心源性休克患者,无绝对禁忌证时应考虑早期PCI,不应仅因年龄排除。
  • 临床判断仍关键,需结合个体情况决定血运重建策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Older adults ≥75 years of age carry an increased risk of mortality after ST-segment elevation myocardial infarction (STEMI) complicated by cardiogenic shock. OBJECTIVES: The purpose of this study was to examine the use of percutaneous coronary intervention (PCI) in older adults with STEMI and shock and its influence on in-hospital mortality. METHODS: We used a large publicly available all-payer inpatient health care database sponsored by the Agency for Healthcare Research and Quality between 1999 and 2013. The primary outcome was in-hospital mortality. The influence of PCI on in-hospital mortality was assessed by quintiles of propensity score (PS). RESULTS: Of the 317,728 encounters with STEMI and shock in the United States, 111,901 (35%) were adults age ≥75 years. Of these, 53% were women and 83% were Caucasians. The median number of chronic conditions was 8 (interquartile range: 6 to 10). The diagnosis of STEMI and cardiogenic shock in older patients decreased significantly over time (proportion of older adults with STEMI and shock: 1999: 42% vs. 2013: 29%). Concomitantly, the rate of PCI utilization in older adults increased (1999: 27% vs. 2013: 56%, p < 0.001), with declining in-hospital mortality rates (1999: 64% vs. 2013: 46%; p < 0.001). Utilizing PS matching methods, PCI was associated with a lower risk of in-hospital mortality across quintiles of propensity score (Mantel-Haenszel odds ratio: 0.48; 95% confidence interval [CI]: 0.45 to 0.51). This reduction in hospital mortality risk was seen across the 4 different U.S. census bureau regions (adjusted odds ratio: Northeast: 0.41; 95% CI: 0.36 to 0.47; Midwest: 0.49; 95% CI: 0.42 to 0.57; South: 0.51; 95% CI: 0.46 to 0.56; West: 0.46; 95% CI: 0.41 to 0.53). CONCLUSIONS: This large and contemporary analysis shows that utilization of PCI in older adults with STEMI and cardiogenic shock is increasing and paralleled by a substantial reduction in mortality. Although clinical judgment is critical, older adults should not be excluded from early revascularization based on age in the absence of absolute contraindications.

来源:J Am Coll Cardiol,查看原文。版权归原作者所有。

引用

  1. Damluji AA, Bandeen-Roche K, Berkower C, et al. Percutaneous Coronary Intervention in Older Patients With ST-Segment Elevation Myocardial Infarction and Cardiogenic Shock. J Am Coll Cardiol. 2019. PMID: 30999991. doi:10.1016/j.jacc.2019.01.055

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。